Fumihiko Urano, MD, PhD
Sees Patients For
Medical genetics, Wolfram syndrome, Wolfram-like syndrome, WFS1-related disorders, genetic testing and counseling, atypical diabetes, genetic forms of diabetes, endocrine genetic diseases.
- Barnes-Jewish Hospital
- Center for Advanced Medicine Diabetes Center4921 Parkview PlaceSt. Louis, MO 63110Suite: BFloor: 13Fax: 314-747-3065Appointments:
- Medical Genetics and Genomics
Academic Title(s)Samuel E. Schechter Professor of Medicine, Professor of Medicine and Pathology & Immunology, Division of Endocrinology, Metabolism and Lipid Research
Wolfram syndrome, gene therapy, regenerative therapy, biomarkers.
Publications & Research
2020 Washington University in St. Louis School of Medicine, St. Louis, MO
2002 New York University School of Medicine, New York, New York
1998 Keio University School of Medicine, Tokyo, Japan
1994 Keio University School of Medicine, Tokyo, Japan
- Equity: Yes
- Reporting Date: 05/01/2023
Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.